Designing of phenol-based β-carbonic anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation approach

3 Biotech
Shahzaib AhamadNeeraja Dwivedi

Abstract

Tuberculosis (Tb) is an airborne infectious disease caused by Mycobacterium tuberculosis. Beta-carbonic anhydrase 1 (β-CA1) has emerged as one of the potential targets for new antitubercular drug development. In this work, three-dimensional quantitative structure-activity relationships (3D-QSAR), molecular docking, and molecular dynamics (MD) simulation approaches were performed on a series of natural and synthetic phenol-based β-CA1 inhibitors. The developed 3D-QSAR model (r2 = 0.94, q2 = 0.86, and pred_r2 = 0.74) indicated that the steric and electrostatic factors are important parameters to modulate the bioactivity of phenolic compounds. Based on this indication, we designed 72 new phenolic inhibitors, out of which two compounds (D25 and D50) effectively stabilized β-CA1 receptor and, thus, are potential candidates for new generation antitubercular drug discovery program.

References

Jun 28, 2002·Journal of Chemical Information and Computer Sciences·Shu-Shen LiuLian-Sheng Wang
Jul 15, 2003·Clinical Microbiology Reviews·Issar Smith
Oct 7, 2003·Annual Review of Microbiology·Josephine E Clark-Curtiss, Shelley E Haydel
Jul 24, 2004·Acta Crystallographica. Section D, Biological Crystallography·Alexander W Schüttelkopf, Daan M F van Aalten
Jan 17, 2007·Journal of Clinical Psychopharmacology·Kenneth A KobakAndrew A Nierenberg
Jun 1, 2000·Nutrition Research Reviews·G G DuthieJ A Kyle
Aug 15, 2009·Biochimica Et Biophysica Acta·Roger S Rowlett
Aug 28, 2010·The Lancet Infectious Diseases·José A CamineroGiovanni Battista Migliori
Feb 22, 2011·Journal of Medicinal Chemistry·Rohan A DavisSally-Ann Poulsen
Jan 5, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Alfonso MarescaClaudiu T Supuran
Jan 28, 2012·Nature·Paul Leeson
Apr 12, 2012·Journal of the National Cancer Institute·Laleh Amiri-Kordestani, Tito Fojo
May 6, 2014·Analytical Biochemistry·Katherine M HoffmannJeffrey M Watson
May 27, 2014·Current Drug Targets·Imran AliHassan Y Aboul-Enein
Dec 1, 2004·Drug Discovery Today. Technologies·Christopher A Lipinski
Mar 1, 2008·Journal of Chemical Theory and Computation·Berk HessErik Lindahl
Dec 3, 2016·Nutrition Journal·Preethi G AnantharajuSubbaRao V Madhunapantula
Dec 6, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Rosella CentisGiovanni Battista Migliori
May 1, 2017·Archives of Pharmacal Research·Shahzaib AhamadMd Imtaiyaz Hassan
Jun 6, 2017·Pharmacology & Therapeutics·Leonardo G Ferreira, Adriano D Andricopulo
Jun 21, 2017·Journal of Enzyme Inhibition and Medicinal Chemistry·Ashok AspatwarSeppo Parkkila
Aug 16, 2017·International Journal of Biological Macromolecules·Khalida NasreenAsimul Islam

❮ Previous
Next ❯

Citations

Mar 7, 2020·Journal of Biomolecular Structure & Dynamics·Ahmad Abu Turab NaqviMd Imtaiyaz Hassan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.